Advaxis, Inc. Announces 1-for-80 Reverse Stock Split
globenewswire.com
news
2022-06-03 00:00:00

MONMOUTH JUNCTION, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS) (the 'Company'), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that it has filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company to implement a one-for-80 reverse split of its issued and outstanding common stock (the 'Reverse Stock Split'). The Reverse Stock Split will become effective as of 12:00am Eastern Time on June 6, 2022, and the Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on June 6, 2022.
